MitchellEugeneGeffnerMD

Chief, Center for Endocrinology, Diabetes, and Metabolism, CHLA, Keck School of Medicine of USC

Dr. Geffner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4650 W Sunset Blvd
Stop 61
Los Angeles, CA 90027
Phone+1 323-669-4606

Fax+1 323-664-0337

Dr. Mitchell Geffner is a pediatric endocrinologist in Hollywood, CA and is affiliated with Children's Hospital Los Angeles. He received his medical degree from Albert Einstein College of Medicine and has been in practice 42 years. He also speaks multiple languages, including Spanish. He is experienced in growth disorders and pediatric diabetes mellitus.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Endocrinology, 1980 - 1982
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1980
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pediatrics, 1975 - 1979
Albert Einstein College of MedicineClass of 1975

PubMed

20 citations
Cardiometabolic health in Turner syndrome.
Shanlee M Davis, Mitchell E. Geffner
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2019-03-01
38 citations
The Optic Nerve Hypoplasia Spectrum: Review of the Literature and Clinical Guidelines.
Anna Ryabets-Lienhard, Carly Stewart, Mark Borchert, Mitchell E. Geffner
Advances in Pediatrics. 2016-08-01
17 citations
A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing
Karen E. Huang, Steven D. Mittelman, Thomas D. Coates, Mitchell E. Geffner, John C. Wood
Journal of Pediatric Hematology/oncology. 2015-01-01

Lectures

Congenital Adrenal Hyperplasia Due to Steroid 21-hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
ENDO 2019 - New Orleans, LA - 3/25/2019

Children’s Hospital Los Angeles Endocrinologist Receives International Outstanding Clinician AwardOctober 28th, 2022
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (Hydrocortisone) in the United StatesNovember 24th, 2020
Hydrocortisone Oral Granules Approved for Pediatric Adrenocortical InsufficiencyNovember 24th, 2020
Join now to see all

Eval Of The Hypothalamic-Pituitary-Adrenal Axis And Adrenomedullary FunctionNational Center For Research Resources2009
Clinical Trial: Studies To Treat Or Prevent Pediatric Type 2 Diabetes (Stopp-T2dNational Center For Research Resources2009
Studies To Treat Or Prevent Pediatric Type 2 Diabetes (Stopp-T2d): TreatmentNational Center For Research Resources2005–2008
Safety And Efficacy Of Growth Hormone From Adolescence To AdulthoodNational Center For Research Resources1999–2001
Prolease Administered In Growth Hormone Deficient ChildrenNational Center For Research Resources1999–2001
Phase I/II Multicenter, OPEN Label Study Of The Efficacy Of Prolease HghNational Center For Research Resources1998–2001
Open-Label, Long-Term Extension Study Of The Safety And Efficacy Of Prolease HghNational Center For Research Resources1998–2001
Dose Ranging Study Of Mk-0677 In Growth Hormone Deficient ChildrenNational Center For Research Resources1998–2001
Study Of The Safety And Efficacy Of Growth Hormone For Gh-Deficient ChildrenNational Center For Research Resources1998
Phase I Pilot Trial Of Dendritic Cell Vaccine In Metastatic Renal Cell CarcinomaNational Center For Research Resources1998
Phase II/III Nutropin Study In Previously Treated GH Deficient AdultsNational Center For Research Resources1996–1997